A cross-reactive neisserial antigen encoded by the NMB0035 locus shows high sequence conservation but variable surface accessibility

Journal of Medical Microbiology

Volumn 57, Issue 1, 2008, Pages 80-87

  Arenas, Jesús ^a   Abel, Ana ^a   Sánchez, Sandra ^a   Marzoa, Juan ^a   Berrón, Sonsoles ^b   Van Der Ley, Peter ^c   Criado, María Teresa ^a   Ferreirós, Carlos M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; P47 ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; FLOW CYTOMETRY; GENE LOCUS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; CONSERVED SEQUENCE; FLOW CYTOMETRY; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS;

EID: 38349035685     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47172-0     Document Type: Article

References (32)

1. Adu-Bobie, J., Capecchi, B., Senisto, D., Rappouli, R. & Pizza, M. (2003). Two years into reverse vaccinology. Vaccine 21, 605-610.
2. Arenas, J. A., Abel, A., Sánchez, S., Alcalá, B., Criado, M. T. & Ferreirós, C. M. (2006). Locus NMB0035 codes for a 47 kDa surface-accessible conserved antigen in Neisseria. Int Microbiol 9, 273-280.
3. Beitz, E. (2000). TeXshade: shading and labeling of multiple sequence alignment using LaTeX2e. Bioinformatics 16, 135-139.
4. Bowden, R. A., Cloeckaert, A., Zygmunt, M. S., Bernard, S. & Dubray, G. (1995). Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry. Infect Immun 63, 3945-3952.
5. Doytchinova, I. A. & Flower, D. R. (2002). Quantitative approaches to computational vaccinology. Immunol Cell Biol 80, 270-279.
6. Gorringe, A. R., Halliwell, D., Matheson, M., Reddin, K., Finney, M. & Hudson, M. (2005). The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Vaccine 23, 2210-2213.
7. Gorter, A. D., Oostrikb, J., van der Ley, P., Hiemstrac, P. S., Dankerta, J. & van Alphen, L. (2003). Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog 34, 121-130.
8. Huang, X. & Madan, A. (1999). CAP3: a DNA sequence assembly program. Genome Res 9, 868-877.
9. Jolley, K. A., Appleby, L., Wright, J. C., Christoloulides, M. & Heckels, J. E. (2001). Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci. Infect Immun 69, 3809-3816.
10. Kahler, C. M., Datta, A., Tzeng, Y. L., Carlson, R. W. & Stephens, D. S. (2005). Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes. Glycobiology 15, 409-419.
11. Khan, A. S., Mujer, C. V., Alefantis, T. G., Connolly, J. P., Mayr, V. B., Walcher, P., Lubilz, W. & DelVecchio, U. G. (2006). Proteomics and bioinformatics strategies to design countermeasures against infectious threat agents. J Chem Inf Model 46, 111-115.
12. Kumar, S., Tamura, K. & Nei, M. (2004). MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5, 150-163.
13. Leclerc, C. L. (2003). New approaches in vaccine development. Comp Immunol Microbiol Infect Dis 26, 329-341.
14. Martin, S. L., Borrow, R., van der Ley, P., Dawson, M., Fox, A. J. & Cartwright, K. A. (2000). Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine 18, 2476-2481.
15. Michaelsen, T. E., Aase, A., Kolberg, J., Wedege, E. & Rosenqvist, E. (2001). PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria. Vaccine 19, 1526-1533.
16. Morley, S. L. & Pollard, A. J. (2001). Vaccine prevention of meningococcal disease, coming soon? Vaccine 20, 666-687.
17. Morley, S. L., Cole, M. J., Ison, C. A., Camaraza, M. A., Sotolongo, M., Anwar, N., Cuevas, I., Carbonero, M., Campa, H. C. & other authors (2001). Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants. Pediatr Infect Dis J 20, 1054-1061.
18. O'Dwyer, C. A., Reddin, K., Martin, D., Taylor, S. C., Gorringe, A. R., Hudson, M. J., Brodeur, B. R., Langford, P. R. & Kroll, J. S. (2004). Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential. Infect Immun 72, 6511-6518.
19. Petrovsky, N. & Brusic, V. (2002). Computational immunology: the coming of age. Immunol Cell Biol 80, 248-254.
20. Pintor, M., Ferrón, L., Gómez, J. A., Powell, N. B. L., Ala'Aldeen, D. A. A., Borrriello, S. P., Criado, M. T. & Ferreiros, C. M. (1996). Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis. Microb Pathog 20, 127-139.
21. Rosenqvist, E., Hoiby, E. A., Wedege, E., Bryn, K., Kolberg, J., Klem, A., Ronnild, E., Bjune, G. & Nokleby, H. (1995). Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun 63, 4642-4652.
22. Steeghs, L., de Cock, H., Evers, E., Zomer, B., Tommassen, J. & van der Ley, P. (2001). Outer membrane composition of a lipopolysaccharide- deficient Neisseria meningitidis mutant. EMBO J 20, 6937-6945.
23. Tappero, J. W., Lagos, R., Ballesteros, A. M., Plikaytis, B., Williams, D., Dykes, J., Gheesling, L. L., Carlone, G. M., Hoiby, E. A. & other authors (1999). Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281, 1520-1527.
24. Troncoso, G., Sanchez, S., Moreda, M., Criado, M. T. & Ferreirós, C. M. (2000). Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species. FEMS Immunol Med Microbiol 27, 103-109.
25. Valdivia, R. H. & Falkow, S. (1998). Flow cytometry and bacterial pathogenesis. Curr Opin Microbiol 1, 359-363.
26. Van de Peer, Y. & De Wachter, R. (1994). TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci 10, 569-570.
27. Welsch, J. A., Moe, G. R., Rossi, R., Adu-Bobie, J., Rappouli, R. & Granoff, D. M. (2003). Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. J Infect Dis 188, 1730-1740.
28. Williams, J. N., Skipp, P. J., Humphries, H. E., Christodoulides, M., O'Connor, C. D. & Heckels, J. E. (2007). Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant. Infect Immun 75, 1364-1372.
29. Yu, K., Petrovsky, Y. K., Schönbach, C., Koh, J. Y. & Brusic, V. (2002). Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol Med 8, 137-148.
30. Zagursky, R. J. & Rusell, D. (2001). Bioinformatics: use in bacterial vaccine discovery. Biotechniques 31, 636-640.
31. Zhang, C., Anderson, A. & DeLisi, C. (1998). Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol 281, 929-947.
32. Zhu, P., Klutch, M. J., Bash, M. C., Tsang, R. S. W., Ng, L. & Tsai, C. (2002). Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species. Microbiology 148, 1833-1844.